| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/25/2009 | EP2039762A2 Nitralases |
| 03/25/2009 | EP2039704A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 03/25/2009 | EP2039703A1 Toxin detection method |
| 03/25/2009 | EP2039369A1 Treatment of fungal infections |
| 03/25/2009 | EP2039368A2 Methods for preventing reactivation of latent virus and controlling virus replication |
| 03/25/2009 | EP2039251A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 03/25/2009 | EP2038416A1 Nitrogen limitation adaptibility gene and protein and modulation thereof |
| 03/25/2009 | EP2038306A1 Anti-nkg2a antibodies and uses thereof |
| 03/25/2009 | EP2038305A1 Antibody molecules which bind human il-17 |
| 03/25/2009 | EP2038304A1 Bst2 inhibitor |
| 03/25/2009 | EP2038297A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 03/25/2009 | EP2037961A2 Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity |
| 03/25/2009 | EP1974213A4 High sensitivity secretagogin assays and their uses for diagnosis and/or prognosis |
| 03/25/2009 | EP1920239A4 Detection and measurement of blood-feeding activity |
| 03/25/2009 | EP1706423B1 Therapeutic and diagnostic anti-hsp 70 antibodies |
| 03/25/2009 | EP1539791A4 Method for distinguishing ulcerative colitis from crohn s di sease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | EP1238282B1 Methods of diagnosis and treatment by binding p75/airm1 |
| 03/25/2009 | EP1110090B1 Multihued labels |
| 03/25/2009 | EP1053010B1 Copolymer compositions for oral delivery |
| 03/25/2009 | CN101395183A Anti-ephb4 antibodies and methods using same |
| 03/25/2009 | CN101395182A Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 03/25/2009 | CN101395181A Influenza antibodies, compositions, and related methods |
| 03/25/2009 | CN101395175A Chicken virus vaccine and diagnostic |
| 03/25/2009 | CN101395162A Hapten compound and antibody |
| 03/25/2009 | CN101392023A Main allergic protein of humulus pollen |
| 03/25/2009 | CN101392022A Monoclonal antibody of main allergic protein of humulus pollen |
| 03/25/2009 | CN100471948C Composition of antibody specifically binding to CD20 |
| 03/25/2009 | CN100471871C Therapeutic human anti-IL-1R1 monoclonal antibody |
| 03/24/2009 | US7507872 Transgenic toll-like receptor 9 (TLR9) mice |
| 03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 03/24/2009 | US7507804 Peptides and nucleic acid sequences related to the Epstein Barr Virus |
| 03/24/2009 | US7507798 Antibody specific for mutant presenilin 1 |
| 03/24/2009 | US7507797 Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 03/24/2009 | US7507796 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507793 Mammalian sweet taste receptors t1r3 |
| 03/24/2009 | US7507787 Polynucleotides; induce immunology response; antiinflammatory agents; detection polynucleotide patten |
| 03/24/2009 | US7507713 purified polypeptide and fusion protein for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; axonal regeneration, side effect reduction of scar tissue formation |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507557 Nucleotide sequences coding proline utilization protein (PUT2) for use as tool in prevention and treatment of insulin metabolic disorders |
| 03/24/2009 | US7507556 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents |
| 03/24/2009 | US7507550 Analytical sandwich test for determining NT-proBNP |
| 03/24/2009 | US7507544 Comprises nucleotide sequences coding mammalian taste-cell-specific G protein-coupled receptors for use in identifying agents which modify chemosensory taste transduction; sweetness and food processing |
| 03/24/2009 | US7507540 determining the presence of catalytic antibodies capable of degrading antihemophilic factors in mammals; analyzing the cleavage sites in the antihemophilic factors; biocatalysts; drugs |
| 03/24/2009 | US7507537 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/24/2009 | US7507532 diagnosis of cancer in patients, by determining the level of oncogene expression in blood and detecting mRNA encoded by polynucleotide in peripheral blood mononuclear cells; screening for moderators and gene expression inhibitors, used for treating cancers in vivo |
| 03/24/2009 | US7507529 genetic amplification of a target nucleic acid in biological samples containing primate T-lymphotropic viruses (PTLVs), include human and simian T-lymphotropic viruses (HTLV and STLV), and detecting the strain of PTLV contained in the sample by determining nucleotide fragments that have been amplified |
| 03/24/2009 | US7507528 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | US7507417 Glycoproteins; antigens |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507412 for drug screening; kits for collagen and/or platelet-collagen interaction; for treatment of thrombotic and cardiovascular events and disorders |
| 03/24/2009 | US7507410 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| 03/24/2009 | US7507408 Anti hepatitis C virus antibody and uses thereof |
| 03/24/2009 | US7507407 Immunoliposomes that optimize internationalization into target cells |
| 03/24/2009 | US7507406 administering immunoglobulins linked to proteins having amino acid replacements in the amino acid sequence, to increase the circulating half-life in vivo than a corresponding antibody-based fusion proteins without amino acid replacements; reducing tumor size and metastasis in mammals |
| 03/24/2009 | US7507404 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 03/24/2009 | US7507403 drugs comprising an isolated protein, mixed with pharmaceutically acceptable carriers, excipients or diluents, used as an immunogenic composition for stimulating or enhancing the production of antibodies directed against the protein |
| 03/24/2009 | CA2466877C Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 03/24/2009 | CA2267456C Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 03/23/2009 | CA2701047A1 Antibody against anthrax toxins |
| 03/19/2009 | WO2009036379A2 Rationally designed, synthetic antibody libraries and uses therefor |
| 03/19/2009 | WO2009036228A2 Hepatitis b pre-s2 nucleic acid |
| 03/19/2009 | WO2009036209A2 Homogeneous antibody populations |
| 03/19/2009 | WO2009036157A1 Donor specific antibody libraries |
| 03/19/2009 | WO2009035786A1 Humanized anti-fgf19 antagonists and methods using same |
| 03/19/2009 | WO2009035617A1 High-pressure refolding of monoclonal antibody aggregates |
| 03/19/2009 | WO2009035577A1 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 03/19/2009 | WO2009035420A1 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 03/19/2009 | WO2009035412A1 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 03/19/2009 | WO2009035357A2 Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method |
| 03/19/2009 | WO2009034779A1 Cancer diagnosis kit and cancer diagnosis method |
| 03/19/2009 | WO2009033743A1 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof |
| 03/19/2009 | WO2009033742A2 Streptococcus pneumoniae vaccines |
| 03/19/2009 | WO2009033670A2 Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection |
| 03/19/2009 | WO2009033309A1 HUMANIZED ANTIBODIES AGAINST THE ß-AMYLOYD PEPTIDE |
| 03/19/2009 | WO2009033259A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/19/2009 | WO2009033233A1 Novel p2x7 epitopes |
| 03/19/2009 | WO2009033212A1 The use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers |
| 03/19/2009 | WO2009007993A3 A process for purification of immunoglobulins using a pseudobioaffinity adsorbent |
| 03/19/2009 | WO2009002790A3 Compositions and methods for treating, reducing, ameliorating, alleviating, or preventing dry eye |
| 03/19/2009 | WO2008153610A3 Use of il-23 antagonists for treatment of infection |
| 03/19/2009 | WO2008143954A3 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto |
| 03/19/2009 | WO2008133722A3 Anti human sclerostin antibodies |
| 03/19/2009 | WO2008130814A3 Use of an mmp28 inhibitor for increasing myelination |
| 03/19/2009 | WO2008091288A3 Microbial synthesis of d-1,2,4-butanetriol |
| 03/19/2009 | WO2008079352A3 Antibodies to cd200r |
| 03/19/2009 | WO2005062977A3 Prostate cancer specific internalizing human antibodies |
| 03/19/2009 | US20090077681 Methods for Diagnosing and Treating Heart Disease |
| 03/19/2009 | US20090077680 Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same |
| 03/19/2009 | US20090077679 Gene silencing by systemic rna interference |
| 03/19/2009 | US20090077677 Mammalian grainyhead transcription factors |
| 03/19/2009 | US20090076251 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |
| 03/19/2009 | US20090076250 recognize selectively both Programmed Death 1 (PD-1) protein and a membrane protein co-existing with PD-1 on a cell membrane, and can transmit a suppressive signal of PD-1; for medical treatment and/or prevention of diseases caused by immune abnormality |
| 03/19/2009 | US20090076249 comprises a heavy chain variable region comprising the amino acid sequence set forth in SEQ ID NO:7 or encoded by the nucleotide sequence set forth in SEQ ID NO:6; inhibiting growth and/or proliferation of a cell expressing CD38 |
| 03/19/2009 | US20090076248 Plus end-directed microtubule motor required for chromosome congression |
| 03/19/2009 | US20090076247 High pressure refolding of monoclonal antibody aggregates |
| 03/19/2009 | US20090075927 Sweet taste receptors |